E1: US Response to COVID-19 & Impact on Startups, VC & Public Markets with David Friedberg

The COVID-19 pandemic demands a shift from broad economic lockdowns to targeted, data-driven strategies centered on mass antibody testing. Current containment policies, while necessary, threaten to trigger a prolonged economic depression by causing massive unemployment and supply chain disruptions. Emerging data suggests a high rate of asymptomatic spread, implying that the true fatality rate may be significantly lower than initial models indicated. To mitigate long-term damage, the federal government must prioritize the rapid distribution of low-cost antibody tests to identify immune individuals and safely reopen the economy. Startups face an existential threat, requiring founders to drastically cut burn rates and extend runway to at least 36 months. Beyond immediate survival, the crisis necessitates a fundamental recalibration of societal values, moving away from conspicuous consumption toward resilient, locally-attuned infrastructure and compassionate capitalism.